BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2966288)

  • 1. DNA nuclear content in borderline ovarian tumors.
    Olinici CD; Căluşer I
    Morphol Embryol (Bucur); 1988; 34(1):49-52. PubMed ID: 2966288
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic significance of DNA content and nuclear morphology in borderline ovarian tumors.
    Drescher CW; Flint A; Hopkins MP; Roberts JA
    Gynecol Oncol; 1993 Feb; 48(2):242-6. PubMed ID: 8428698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear deoxyribonucleic acid heterogeneity of ovarian borderline malignant serous tumors.
    Fu YS; Ro J; Reagan JW; Hall TL; Berek J
    Obstet Gynecol; 1986 Apr; 67(4):478-82. PubMed ID: 3960418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear deoxyribonucleic acid content (ploidy) of endodermal sinus (yolk sac) tumor.
    Kommoss F; Bibbo M; Talerman A
    Lab Invest; 1990 Feb; 62(2):223-31. PubMed ID: 2304335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized image analysis and flow cytometric evaluation of ovarian borderline tumors: a study of 24 cases.
    Esposito MJ; Fuchs A
    Cytometry; 1994 Dec; 18(4):218-22. PubMed ID: 7895528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of DNA content by means of cytophotometry. Technical and methodological considerations and its application in tumor pathology].
    Roa I; Villaseca M; Wistuba I; Araya JC; De Aretxabala X
    Rev Med Chil; 1993 Aug; 121(8):897-902. PubMed ID: 8296097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study and application of the DNA pattern in oncology].
    de Aretxabala X; Roa I; Araya JC; Roa JC
    Rev Med Chil; 1989 Sep; 117(9):1044-8. PubMed ID: 2519471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
    Liu C; Zhao Y; Sun X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas.
    Osterberg L; Akeson M; Levan K; Partheen K; Zetterqvist BM; Brännström M; Horvath G
    Cancer Genet Cytogenet; 2006 Jun; 167(2):103-8. PubMed ID: 16737908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of nuclear DNA content in laryngeal tumors].
    Garozzo A; Rossi M; Denaro A; Allegra E; Santangelo G; Amato CM; Tomasello C
    Acta Otorhinolaryngol Ital; 1988; 8(2):117-23. PubMed ID: 3188901
    [No Abstract]   [Full Text] [Related]  

  • 11. Flow cytometry as a prognostic indicator in women with borderline epithelial ovarian tumors.
    Harlow BL; Fuhr JE; McDonald TW; Schwartz SM; Beuerlein FJ; Weiss NS
    Gynecol Oncol; 1993 Sep; 50(3):305-9. PubMed ID: 8406192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.
    Hedley DW; Friedlander ML; Taylor IW
    Cytometry; 1985 Jul; 6(4):327-33. PubMed ID: 4017799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination between benign, borderline, and malignant epithelial ovarian tumors using tumor markers: an immunohistochemical study.
    Dietel M
    Cancer Detect Prev; 1983; 6(1-2):255-62. PubMed ID: 6192920
    [No Abstract]   [Full Text] [Related]  

  • 14. [DNA cytophotometry of oxyphilic thyroid tumors].
    Pilch H; Back W; Winter J
    Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear DNA content in different histologic types of breast carcinoma.
    Olinici CD; Căluşer I
    Morphol Embryol (Bucur); 1988; 34(4):243-7. PubMed ID: 2976886
    [No Abstract]   [Full Text] [Related]  

  • 16. [Assay of DNA content and estrogen receptor status in human breast cancer].
    Chen GJ; Shao YF; Shan Y
    Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):461-4. PubMed ID: 7720507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of DNA content in salivary gland tumors].
    Yáñez M; Roa I; Villaseca M; Fuentealba P
    Rev Med Chil; 1997 Oct; 125(10):1177-81. PubMed ID: 9609036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of nuclear DNA content in serous ovarian tumors.
    Erhardt K; Auer G; Björkholm E; Forsslund G; Moberger B; Sifverswärd C; Wicksell G; Zetterberg A
    Cancer Res; 1984 May; 44(5):2198-202. PubMed ID: 6713406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cervix uteri cancer: determination of DNA content by means of cytophotometry].
    Wistuba I; Roa I; Villaseca MA; Araya JC; Capurro I
    Rev Med Chil; 1993 Aug; 121(8):873-9. PubMed ID: 8296094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA content of mucinous tumors of the ovary.
    Weiss RR; Richart RM; Okagaki T; Cottral GA
    Am J Obstet Gynecol; 1969 Feb; 103(3):409-24. PubMed ID: 5763126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.